Assay performance improved, but which "scorecard" designation for Vitros Troponin I?

Clinica Chimica Acta

Volumn 413, Issue 7-8, 2012, Pages 826-828

  Zaninotto, M ^a   Vernocchi, A ^b   Di Serio, F ^c   Del Mar Viloria, M ^d   Hurtado, Josè M ^e   Perez Guerrero, J J ^f   Plebani, M ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

^c POLICLINICO   (Italy)

^d HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^e HOSPITAL SAN AGUSTÍN   (Spain)

^f Hospital Comarcal de Baza   (Spain)

Author keywords

99th percentile reference values; New generation assays; Scorecard classification; Troponin I

Indexed keywords

HEPARIN; LITHIUM; TROPONIN I;

ACCURACY; ADULT; AGED; ANALYTICAL PARAMETERS; BLOOD ANALYSIS; BLOOD SAMPLING; COEFFICIENT OF VARIATION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; LETTER; LIMIT OF BLANK; LIMIT OF DETECTION; MALE; MULTICENTER STUDY; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; SERUM; STATISTICAL PARAMETERS; TEST RETEST RELIABILITY;

HUMANS; LIMIT OF DETECTION; REPRODUCIBILITY OF RESULTS; TROPONIN I;

EID: 84857654000     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.017     Document Type: Letter

References (10)

1. Apple F.S., Jesse R.L., Newby L.K., et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007, 53:547-551.
2. Hamm C.V., Bassand J.P., Agewall S., et al. The task force for the management of acute coronary syndrome (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011, 32:2999-3054.
3. Thygensen K., Mair J., Katus H., et al. Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Recommendations for the use of cardiac troponins measurement in acute cardiac care. Eur Heart J 2010, 31:2197-2206.
4. Apple F.S. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009, 55:1303-1306.
5. National Committee for Clinical Laboratory Standards Protocols for determination of limits of detection and limit of quantitation; approved guideline. NCCLS guideline EP17-A. Wayne, PA: NCCLS October 2004.
6. National Committee for Clinical Laboratory Standards Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5-A. Wayne, PA: NCCLS 1999.
7. National Committee for Clinical Laboratory Standards Evaluation of the linearity of quantitative measurement procedures: a statistical approach; proposed guideline. NCCLS guideline EP6-P. Wayne, PA: NCCLS 1986.
8. Sasse E.A. How to define and determine reference intervals in the clinical laboratory. NCCLS document C28-A, Wayne, PA: NCCLS 2002.
9. Apple S., Collinson P.O. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012, 58:54-61. for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers.
10. Jaffe A.S., Apple F.S., Morrow D.A., et al. Being rational about (im)precision: a statement from Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction. Clin Chem 2010, 56:941-943.